ArticleJournal of gastrointestinal oncology2024
Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer.
Gareth Pollin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it